Neurotrophic Keratopathy Completed Phase 2 Trials for Varenicline (DB01273)
Also known as: Neurotrophic Keratitis / Neurotrophic keratitis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0077055 (Neurotrophic Keratopathy) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04957758 | Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy | Treatment |